The American journal of managed care
-
To determine the need for routine third-trimester antibody screening in Rh+ women. ⋯ Based on the patient and hospital records studied, a repeat third-trimester antibody screen for Rh+ patients is clinically and economically unjustified. Eliminating this laboratory test from clinical practice will not adversely affect pregnancy outcomes and will decrease the costs of prenatal care.